Learning Objectives:

  1. To understand current epidemiology and pathology of nonalcoholic fatty liver disease
  2. To appreciate unique aspects of nonalcoholic fatty liver disease in the context of liver transplantation
  3. To understand how nonalcoholic fatty liver disease can affect immunosuppression
Session date: 
Friday, May 10, 2019 - 12:30pm to 1:30pm
Speaker Name: 
Michael Charlton, MD
Location: 
University of Chicago
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.